Involvement of PI3K/Akt/CREB and redox changes in mitochondrial defect of osteoblastic MC3T3-E1 cells

Eun Mi Choi1, Young Soon Lee

  • 1Department of Food and Nutrition, Kyung Hee University, 1, Hoegi-Dong, Dongdaemun-gu, Seoul 130-701, Republic of Korea. cheunmi@hanmail.net

Insights

Antimycin A damages osteoblasts by inhibiting mitochondrial electron transport. This leads to reduced pyridine nucleotides (NAD+ and NADPH) and impaired PI3K/Akt/CREB signaling, impacting osteoblast function.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Mitochondrial Biology

Background:

  • Antimycin A (AMA) inhibits mitochondrial electron transport at complex III.
  • Understanding AMA's cellular damage mechanisms is crucial for osteoblast health.

Purpose of the Study:

  • To investigate the mechanisms underlying Antimycin A-induced cell damage in osteoblasts.
  • To explore the role of pyridine nucleotides and the PI3K/Akt/CREB pathway in AMA's effects.

Main Methods:

  • Treatment of MC3T3-E1 osteoblastic cells with Antimycin A.
  • Measurement of cellular levels of adenosine 3',5'-cyclic monophosphate (cAMP), NAD+, NADH, NADP+, and NADPH.
  • Assay of phosphoinositide 3-kinase (PI3K), Akt, phosphorylated CREB, aconitase, and thioredoxin reductase activities.

Main Results:

  • AMA treatment decreased cAMP levels, PI3K, Akt, and phosphorylated CREB.
  • AMA significantly reduced NAD+ and NADPH levels in osteoblasts.
  • Activities of aconitase and thioredoxin reductase were diminished by AMA.

Conclusions:

  • The PI3K/Akt/CREB pathway is implicated in Antimycin A-induced osteoblast damage.
  • Pyridine nucleotides (NAD+ and NADPH) are involved in the mitochondrial dysfunction caused by AMA.
  • AMA affects osteoblast mitochondrial function through these pathways.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...